日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Improving cardiovascular risk stratification through the derivation and validation of an elevated triglyceride-glucose index

通过推导和验证升高的甘油三酯-葡萄糖指数来改善心血管风险分层

Mavraganis, Georgios; Georgiopoulos, Georgios; Athanasopoulos, Stavros; Terentes-Printzios, Dimitrios; Zervas, Georgios; Konstantaki, Christina; Koilakou, Maria Eleni; Giannakopoulou, Sofia-Panagiota; Dimopoulou, Maria-Angeliki; Chrysochoou, Christina; Tsioufis, Konstantinos; Pitsavos, Christos; Liberopoulos, Evangelos; Stellos, Konstantinos; Vlachopoulos, Charalambos; Panagiotakos, Demosthenes; Stamatelopoulos, Kimon

Amyloid-beta (1-40) peptide is associated with systemic metabolic health

β-淀粉样蛋白(1-40)肽与全身代谢健康相关

Sopova, Kateryna; Delialis, Dimitrios; Aivalioti, Evmorfia; Georgiopoulos, Georgios; Athanasopoulos, Stravros; Zervas, Georgios; Konstantaki, Christina; Sachse, Marco; Sigl, Martin; Duerschmied, Daniel; Tual-Chalot, Simon; Stamatelopoulos, Kimon; Stellos, Konstantinos

Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?

心脏淀粉样变性的损伤机制和治疗方法:炎症在其中扮演什么角色?

Bellofatto, Ilaria Anna; Nikolaou, Panagiota Efstathia; Andreadou, Ioanna; Canepa, Marco; Carbone, Federico; Ghigo, Alessandra; Heusch, Gerd; Kleinbongard, Petra; Maack, Christoph; Podesser, Bruno K; Stamatelopoulos, Kimon; Stellos, Konstantinos; Vilahur, Gemma; Montecucco, Fabrizio; Liberale, Luca

Imidazole propionate is a driver and therapeutic target in atherosclerosis.

咪唑丙酸酯是动脉粥样硬化的驱动因素和治疗靶点

Mastrangelo Annalaura, Robles-Vera Iñaki, Mañanes Diego, Galán Miguel, Femenía-Muiña Marcos, Redondo-Urzainqui Ana, Barrero-Rodríguez Rafael, Papaioannou Eleftheria, Amores-Iniesta Joaquín, Devesa Ana, Lobo-González Manuel, Carreras Alba, Beck Katharina R, Ivarsson Sophie, Gummesson Anders, Georgiopoulos Georgios, Rodrigo-Tapias Manuel, Martínez-Cano Sarai, Fernández-López Ivan, Nuñez Vanessa, Ferrarini Alessia, Inohara Naohiro, Stamatelopoulos Kimon, Benguría Alberto, Cibrian Danay, Sánchez-Madrid Francisco, Alonso-Herranz Vanesa, Dopazo Ana, Barbas Coral, Vázquez Jesús, López Juan Antonio, González-Martín Alicia, Nuñez Gabriel, Stellos Konstantinos, Bergström Göran, Bäckhed Fredrik, Fuster Valentín, Ibañez Borja, Sancho David

Unravelling heart failure cellular signalling heterogeneity with spatial transcriptomics

利用空间转录组学揭示心力衰竭细胞信号传导异质性

Tual-Chalot, Simon; Stellos, Konstantinos

Amyloid-beta metabolism in age-related neurocardiovascular diseases

年龄相关神经心血管疾病中的β-淀粉样蛋白代谢

Aivalioti, Evmorfia; Georgiopoulos, Georgios; Tual-Chalot, Simon; Bampatsias, Dimitrios; Delialis, Dimitrios; Sopova, Kateryna; Drakos, Stavros G; Stellos, Konstantinos; Stamatelopoulos, Kimon

Targeting autophagy to treat neointimal hyperplasia in vascular disease

靶向自噬治疗血管疾病中的新生内膜增生

Yan, Runan; Tual-Chalot, Simon; Stellos, Konstantinos

Targeting RNA adenosine editing and modification enzymes for RNA therapeutics

靶向RNA腺苷编辑和修饰酶的RNA疗法

Vlachogiannis, Nikolaos I; Polycarpou-Schwarz, Maria; Avdi, Aikaterini-Paraskevi; Tual-Chalot, Simon; Stellos, Konstantinos

State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases

心力衰竭基因治疗的最新进展和展望。欧洲心脏病学会心力衰竭协会、欧洲心脏病学会心血管基因组学委员会和欧洲心脏病学会心肌及心包疾病工作组的科学声明。

Van Linthout, Sophie; Stellos, Konstantinos; Giacca, Mauro; Bertero, Edoardo; Cannata, Antonio; Carrier, Lucie; Garcia-Pavia, Pablo; Ghigo, Alessandra; González, Arantxa; Haugaa, Kristina H; Imazio, Massimo; Lopes, Luis R; Most, Patrick; Pollesello, Piero; Schunkert, Heribert; Streckfuss-Bömeke, Katrin; Thum, Thomas; Tocchetti, Carlo Gabriele; Tschöpe, Carsten; van der Meer, Peter; van Rooij, Eva; Metra, Marco; Rosano, Giuseppe M C; Heymans, Stephane

Synbiotics and Gut-Heart Axis in Cardiometabolic Disease

益生菌与肠-心轴在心血管代谢疾病中的作用

Sachse, Marco; Stellos, Konstantinos